UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

___________________
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2010

Commission File Number 1-32186
___________________

YM BioSciences Inc.
(Translation of registrant's name into English)

Suite 400, Building 11
5045 Orbitor Drive
Mississauga, Ontario
Canada  L4W 4Y4
( Address of principal executive offices )
___________________


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F R          Form 40-F £

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)   £

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)   £
 
 



 
INCORPORATION BY REFERENCE

Exhibit 99.1 to this Form 6-K is hereby incorporated by reference as an exhibit to the Registration Statement on Form F-10 (File No. 333-161786) of YM Biosciences Inc.

DOCUMENTS FILED

See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
  YM BIOSCIENCES INC.  
     
       
  By: /s/ Leonard Vernon  
  Name:   Leonard Vernon  
 
Title:
Vice President, Finance and Administration  
       
 
Date:  April 26, 2010
 
2

 
EXHIBIT INDEX

Exhibit
Description
 
     
99.1
Sales Agreement
 
     
 
3

YM Biosciences (AMEX:YMI)
過去 株価チャート
から 6 2024 まで 7 2024 YM Biosciencesのチャートをもっと見るにはこちらをクリック
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 7 2023 まで 7 2024 YM Biosciencesのチャートをもっと見るにはこちらをクリック